The article, writen by researchers at th Keio University School of Medicine, investigates the therapeutic potential of human amniotic fluid stem cells (hAFSCs) for inflammation-induced preterm birth using a preterm mouse model of ascending infection. The study demonstrates that hAFSC (grown using PrimeSurface 96U (MS-9096UZ) administration significantly reduces inflammation-induced preterm birth, suppresses inflammation of the placenta and cervix, and switches peritoneal macrophages from an inflammatory to an anti-inflammatory type, suggesting hAFSCs’ effectiveness in treating and preventing inflammation-induced preterm birth.

Read the Full Article